Medicare reform is slowing a prominent state effort to expand prescription drug coverage to low-income individuals. Maine officials indefinitely delayed the state's controversial program to provide some 275,000 low-income residents with price discounts on prescription drugs, saying they needed time to evaluate the effect of the new federal Medicare reform act. The program, Maine Rx Plus, was set to take effect Jan. 1. But state officials want to determine how to handle residents who will qualify for both state and federal benefits, perhaps offsetting some of the need for Maine Rx Plus, said Trish Riley, director of the governor's Office of Health Policy and Finance. "Our goal is to get a decision and get action this month," Riley said. -- by Jeff Tieman
Maine delays new prescription drug program
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.